Unique ID issued by UMIN | UMIN000035147 |
---|---|
Receipt number | R000040060 |
Scientific Title | An investigation study for lifting up the skin improvement with ingestion of proteoglycan for 12 weeks on Japanese adult women |
Date of disclosure of the study information | 2018/12/05 |
Last modified on | 2022/05/31 10:29:56 |
An investigation study for lifting up the skin improvement with ingestion of proteoglycan for 12 weeks on Japanese adult women
An investigation study for lifting up the skin improvement with ingestion of proteoglycan for 12 weeks on Japanese adult women
An investigation study for lifting up the skin improvement with ingestion of proteoglycan for 12 weeks on Japanese adult women
An investigation study for lifting up the skin improvement with ingestion of proteoglycan for 12 weeks on Japanese adult women
Japan |
Healthy Japanese subjects
Not applicable | Adult |
Others
NO
To verify the improvement in skin lifting with the test food in Japanese adult women.
Efficacy
Confirmatory
Pragmatic
Not applicable
The ratio of the long axis of an ellipse of the stamps of lying down position and standing position
* Put a stamp on the cheek at lying down position and standing position, and evaluate the long axis of an ellipse of the stamps of both positions
* Assess the measured value at screening (before consumption) and at 4, 8, and 12 weeks after consumption and calculate the amount of change.
1. The difference of the long axis of an ellipse of the stamps between lying down position and standing position
2. Moisture of the skin
3. Transepidermal Water Loss (TEWL)
4. Viscoelasticity of the skin
5. Facial pigmentations
6. Wrinkles on facial skin
7. Facial skin texture
8. Facial pores
9. Facial skin tone
10. Facial redness
11. Measure lift up the skin (3D)
12. Measure the dermis
13. Questionnaire (the Likert scale)
*1-13 Assess the measured value at screening (before consumption) and at 4, 8, and 12 weeks after consumption and calculate the amount of change.
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Food |
Duration: 12 weeks
Test food: Capsule containing salmon nasal cartilage-derived proteoglycan
Administration: Take one capsule after dinner with water
* Daily dose should be taken within the day. If you forget to take the capsule, take it as soon as you remember within the day.
Duration: 12 weeks
Test food: Placebo capsule
Administration: Take one capsule after dinner with water
* Daily dose should be taken within the day. If you forget to take the capsule, take it as soon as you remember within the day.
20 | years-old | <= |
Not applicable |
Female
1. Healthy Japanese adult women
2. Subjects who are experiencing sagging the skin
3. Subjects who are judged as eligible to participate in the study by the dermatologist
4. Subjects whose ratio of the long axis of an ellipse of the stamps of lying down position and standing position are relatively large
1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure or myocardial infarction
2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD)
3. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or other chronic diseases
4. Subjects who use or take "Foods for Specified Health Uses", "Foods with Function Claims", or other functional food/beverage in daily
5. Subjects who have been diagnosed with atopic dermatitis
6. Subjects who use any other products except for cosmetic creams, beauty essence, all-in-one cosmetic makeup, and face masks, skin lotions, milky lotions, and sunscreen, for daily skincare.
7. Subjects who habitually receive skincare treatment (e.g., aesthetic treatment) or use instruments for beauty treatment (e.g., facial treatment device)
8. Subjects who are currently taking medications (including herbal medicines) and dietary supplements, particularly allergic to salmon
9. Subjects who are allergy to medications and/or products that contain the study ingredients. Particularly, salmon allergy
10. Subjects who are pregnant, breast-feeding, or planning to become pregnant
11. Subjects who have been participated in another clinical study within the last three months prior to signing informed consent for the current study
12. Subjects who are ineligibility to participate in the study based on the evaluation of the principal dermatologist
52
1st name | |
Middle name | |
Last name | Kazuo YAMAMOTO |
ORTHOMEDICO Inc.
CEO
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan.
03-3818-0610
kazu@orthomedico.jp
1st name | |
Middle name | |
Last name | Naoko SUZUKI |
ORTHOMEDICO Inc.
R&D Department
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan.
03-3818-0610
nao@orthomedico.jp
ORTHOMEDICO Inc.
NIHON PHARMACEUTICAL CO.,LTD.
Profit organization
Hiroo Dermatology Clinic & Mentors inc.
NO
広尾皮フ科クリニック (東京都)
Hiroo Dermatology Clinic & Mentors inc. (Tokyo, Japan)
医療法人社団盛心会 タカラクリニック (東京都)
Medical Corporation Seishinkai, Takara Clinic (Tokyo, Japan)
2018 | Year | 12 | Month | 05 | Day |
Unpublished
Completed
2018 | Year | 11 | Month | 12 | Day |
2018 | Year | 11 | Month | 12 | Day |
2018 | Year | 12 | Month | 05 | Day |
2019 | Year | 06 | Month | 01 | Day |
2018 | Year | 12 | Month | 05 | Day |
2022 | Year | 05 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040060